• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国结节性痒疹常规护理评估:回顾性病历审查研究(ADVANCE PN)

Evaluation of routine care of prurigo nodularis in Germany: retrospective chart review study (ADVANCE PN).

作者信息

von Kiedrowski Ralph, Metz Martin, Weisshaar Elke, Albrecht Inka, Schild Marie, Ständer Sonja

机构信息

Company for Medical Study & Service Selters and Private Practice Dermatology, Selters/Westerwald, Germany.

Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

出版信息

J Dtsch Dermatol Ges. 2025 Jul;23(7):844-855. doi: 10.1111/ddg.15721. Epub 2025 Jun 8.

DOI:10.1111/ddg.15721
PMID:40484725
Abstract

BACKGROUND AND OBJECTIVES

Knowledge on patient care gaps of prurigo nodularis (PN) is limited. This retrospective chart review (ADVANCE PN) investigated unmet medical needs and gaps in diagnostics, treatment, and management of patients with PN in routine care in Germany.

PATIENTS AND METHODS

Medical records for adults newly diagnosed with PN between January 2012 and December 2022 from dermatologic clinics and office-based dermatologists were analyzed. Baseline demographics, treatment patterns, diagnostics, symptoms, patient-reported outcomes (PROs), and disease-specific scores are reported.

RESULTS

Records of 363 patients from 42 sites were analyzed. Median age (range) was 67 (19-95) years; most patients were female (61.7%), Caucasian (73.4%), and retired (57.3%). Overall, 209 (62.2%) patients had comorbidities (most common: hypertension [28.3%]). Clinically, most patients had nodules (81.1%) or papules (66.7%). PROs, disease-specific scores, and laboratory assessments were performed for 32 (8.8%), 12 (3.3%), and 71 (19.7%) patients, respectively. Topical corticosteroids (TCS) were the most common overall (90.9%) and first-line therapy (84.9%); for second-line therapy, 'no further treatment' was most commonly documented (58.6%).

CONCLUSIONS

The findings of ADVANCE PN indicate a high unmet need in the current state of medical care, evidenced by shortcomings in PRO assessment, PN documentation, and adherence to guidelines on PN.

摘要

背景与目的

关于结节性痒疹(PN)患者护理差距的知识有限。这项回顾性图表审查(ADVANCE PN)调查了德国常规护理中PN患者未满足的医疗需求以及诊断、治疗和管理方面的差距。

患者与方法

分析了2012年1月至2022年12月期间皮肤科诊所和门诊皮肤科医生新诊断为PN的成年患者的病历。报告了基线人口统计学、治疗模式、诊断、症状、患者报告结局(PROs)和疾病特异性评分。

结果

分析了来自42个地点的363例患者的记录。中位年龄(范围)为67(19 - 95)岁;大多数患者为女性(61.7%)、白种人(73.4%)且已退休(57.3%)。总体而言,209例(62.2%)患者有合并症(最常见的是高血压[28.3%])。临床上,大多数患者有结节(81.1%)或丘疹(66.7%)。分别对32例(8.8%)、12例(3.3%)和71例(19.7%)患者进行了PROs、疾病特异性评分和实验室评估。外用糖皮质激素(TCS)是最常用的总体治疗方法(90.9%)和一线治疗方法(84.9%);对于二线治疗,最常记录的是“不再进一步治疗”(58.6%)。

结论

ADVANCE PN的研究结果表明,目前医疗护理状况存在高度未满足的需求,PRO评估、PN记录以及对PN指南的遵循方面的不足证明了这一点。

相似文献

1
Evaluation of routine care of prurigo nodularis in Germany: retrospective chart review study (ADVANCE PN).德国结节性痒疹常规护理评估:回顾性病历审查研究(ADVANCE PN)
J Dtsch Dermatol Ges. 2025 Jul;23(7):844-855. doi: 10.1111/ddg.15721. Epub 2025 Jun 8.
2
Long-term (68 weeks) administration of nemolizumab and topical corticosteroids for prurigo nodularis in patients aged ≥ 13 years: efficacy and safety data from a phase II/III study.≥13岁结节性痒疹患者长期(68周)使用奈莫利单抗和外用皮质类固醇:一项II/III期研究的疗效和安全性数据
Br J Dermatol. 2025 Jun 20;193(1):56-65. doi: 10.1093/bjd/ljaf045.
3
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years.尼莫利珠单抗联合外用皮质类固醇治疗结节性痒疹的疗效和安全性:一项在年龄≥13 岁患者中进行的随机、双盲、安慰剂对照的 II/III 期临床研究结果。
Br J Dermatol. 2024 Jul 16;191(2):200-208. doi: 10.1093/bjd/ljae131.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Prurigo Nodularis PaTient-Reported BurdEn of SicKness (PN TREK): A Cross-Sectional Survey of Patient-Reported Burden of Disease in Patients with PN from the US.结节性痒疹患者报告的疾病负担(PN TREK):一项来自美国的结节性痒疹患者疾病负担报告的横断面调查。
Adv Ther. 2025 Jul;42(7):3455-3471. doi: 10.1007/s12325-025-03217-4. Epub 2025 May 29.
6
Effectiveness and Safety of Dupilumab for Prurigo Nodularis in China: A Multicentric and Observational Study.度普利尤单抗治疗中国结节性痒疹的有效性和安全性:一项多中心观察性研究
Allergy. 2025 May;80(5):1428-1435. doi: 10.1111/all.16478. Epub 2025 Jan 21.
7
Topical anti-inflammatory treatments for eczema: network meta-analysis.外用抗炎治疗湿疹:网状荟萃分析。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015064. doi: 10.1002/14651858.CD015064.pub2.
8
Non-Systemic Medication for the Treatment of Prurigo Nodularis: A Systematic Review.用于治疗结节性痒疹的非系统性药物:一项系统评价
J Cutan Med Surg. 2024 Mar-Apr;28(2):173-177. doi: 10.1177/12034754241227634. Epub 2024 Jan 30.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Multifaceted behavioral interventions to improve topical glaucoma therapy adherence in adults.多方面行为干预以提高成人局部青光眼治疗的依从性。
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD015788. doi: 10.1002/14651858.CD015788.pub2.

本文引用的文献

1
Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real-world evidence claims data study.与德国基准相比,结节性痒疹患者的合并症、医疗资源利用和治疗模式:真实世界证据索赔数据研究。
J Eur Acad Dermatol Venereol. 2024 May;38(5):883-894. doi: 10.1111/jdv.19700. Epub 2023 Dec 11.
2
S2k guideline: Diagnosis and treatment of chronic pruritus.S2k 指南:慢性瘙痒症的诊断与治疗。
J Dtsch Dermatol Ges. 2022 Oct;20(10):1387-1402. doi: 10.1111/ddg.14830.
3
Chronic Prurigo: Similar Clinical Profile and Burden Across Clinical Phenotypes.
慢性痒疹:不同临床表型的相似临床特征与负担
Front Med (Lausanne). 2021 Jun 29;8:649332. doi: 10.3389/fmed.2021.649332. eCollection 2021.
4
Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction.慢性结节性痒疹:一项欧洲横断面研究,探讨患者对治疗目标和满意度的看法。
Acta Derm Venereol. 2021 Feb 17;101(2):adv00403. doi: 10.2340/00015555-3726.
5
Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.德国结节性痒疹与银屑病的流行病学比较:一项索赔数据库分析。
Acta Derm Venereol. 2020 Nov 4;100(18):adv00309. doi: 10.2340/00015555-3655.
6
The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin: A comparative, retrospective, explorative statistical analysis of 4,484 patients in a real-world cohort.慢性瘙痒症的负担:与非皮损皮肤慢性瘙痒症患者相比,慢性瘙痒症患者的负担更大:一项真实世界队列中 4484 例患者的比较、回顾性、探索性统计分析。
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):738-743. doi: 10.1111/jdv.16929. Epub 2020 Nov 6.
7
Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment.325例慢性结节性痒疹患者的分析:临床特征、疾病负担及治疗过程
Acta Derm Venereol. 2020 Sep 30;100(16):adv00269. doi: 10.2340/00015555-3571.
8
Prurigo nodularis: Pathogenesis and management.结节性痒疹:发病机制与治疗。
J Am Acad Dermatol. 2020 Dec;83(6):1567-1575. doi: 10.1016/j.jaad.2020.04.182. Epub 2020 May 24.
9
Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study.慢性结节性痒疹:临床特征与负担。一项欧洲横断面研究。
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2373-2383. doi: 10.1111/jdv.16309. Epub 2020 May 12.
10
Methods of sample size calculation in descriptive retrospective burden of illness studies.描述性回顾性疾病负担研究中的样本量计算方法。
BMC Med Res Methodol. 2019 Jan 9;19(1):9. doi: 10.1186/s12874-018-0657-9.